DFFN
NASDAQDiffusion Pharmaceuticals Inc.
Diffusion Pharmaceuticals Inc. (DFFN) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for DFFN in the last 30 days. The most recent was published Feb 14, 2024.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Diffusion Pharmaceuticals Inc. (Amendment)SC 13G/A - CervoMed Inc. (0001053691) (Subject)
- INSIDERSEC Form 4 filed by Boger Joshua S4 - CervoMed Inc. (0001053691) (Issuer)
- 13D/GSEC Form SC 13D filed by Diffusion Pharmaceuticals Inc.SC 13D - CervoMed Inc. (0001053691) (Subject)
- INSIDERNew insider Boger Joshua S claimed ownership of 561,309 shares (SEC Form 3)3 - CervoMed Inc. (0001053691) (Issuer)
- SECDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits8-K - CervoMed Inc. (0001053691) (Filer)
- SECDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits8-K - CervoMed Inc. (0001053691) (Filer)
- INSIDERSEC Form 4 filed by Alam John J4 - CervoMed Inc. (0001053691) (Issuer)
- INSIDERSEC Form 4 filed by Blackburn Kelly4 - CervoMed Inc. (0001053691) (Issuer)
- INSIDERSEC Form 4 filed by Tanner John William4 - CervoMed Inc. (0001053691) (Issuer)
- INSIDERSEC Form 4 filed by Elder William Robert4 - CervoMed Inc. (0001053691) (Issuer)
- INSIDERSEC Form 4 filed by Gregoire Sylvie4 - CervoMed Inc. (0001053691) (Issuer)
- INSIDERSEC Form 4 filed by Cobuzzi Robert Joseph Jr.4 - CervoMed Inc. (0001053691) (Issuer)
- SECDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - CervoMed Inc. (0001053691) (Filer)
- SECDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - CervoMed Inc. (0001053691) (Filer)
- SECDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - CervoMed Inc. (0001053691) (Filer)
- INSIDERSEC Form 4 filed by Tanner John William4 - CervoMed Inc. (0001053691) (Issuer)
- SECDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits8-K - CervoMed Inc. (0001053691) (Filer)
- SECDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - CervoMed Inc. (0001053691) (Filer)
- SECSEC Form 10-Q filed by Diffusion Pharmaceuticals Inc.10-Q - CervoMed Inc. (0001053691) (Filer)
- INSIDERGregoire Sylvie gifted 10,000 shares, decreasing direct ownership by 1% to 732,039 units (SEC Form 4)4 - CervoMed Inc. (0001053691) (Issuer)
- INSIDERAlam John J gifted 12,500 shares, decreasing direct ownership by 2% to 729,539 units (SEC Form 4)4 - CervoMed Inc. (0001053691) (Issuer)
- SECDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - CervoMed Inc. (0001053691) (Filer)
- SECDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - CervoMed Inc. (0001053691) (Filer)
- SECDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - CervoMed Inc. (0001053691) (Filer)
- SECDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - CervoMed Inc. (0001053691) (Filer)
DFFN FAQ
6 questionsWhat does Diffusion Pharmaceuticals Inc. do?
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company is also developing DFN-529, a phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway inhibitor. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.What is the latest news on DFFN?
Quantisnow has not tracked any new filings, ratings or press releases for DFFN in the last 30 days. The most recent wire item was published on February 14, 2024.Where does DFFN stock trade?
Diffusion Pharmaceuticals Inc. (DFFN) is listed on NASDAQ.What sector and industry is DFFN in?
Diffusion Pharmaceuticals Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What companies are similar to DFFN?
Notable peers in the same industry include NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABT (Abbott Laboratories), MRK (Merck & Company Inc.). Compare DFFN side-by-side with any of them on Quantisnow.How can I track DFFN on Quantisnow?
Quantisnow aggregates Diffusion Pharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DFFN to receive live email and push alerts on every new disclosure.